−0.192 SEK
−42.45 M SEK
57.44 M SEK
204.41 M
About IDL DIAGNOSTICS AB
Sector
Industry
CEO
Anders Hultman
Website
Headquarters
Bromma Stockholm
Founded
2000
ISIN
SE0003883990
FIGI
BBG001Y25Z48
IDL Diagnostics AB is a in vitro diagnostics company, which engages in the monitoring of hematological malignancies, breast cancer, and other solid tumors. Its products include AroCell TK 210 ELISA, which was designed for simple, robust, and scalable measurement of Thymidine Kinase 1 in blood samples. The company was founded by Karl Axel Staffan Eriksson, Arne Ferstad, Qi Min He, Per Nils Jesper Matsson, Sven Skog, and Bernhard Tribukait in 2003 and is headquartered in Stockholm, Sweden.
Related stocks
Frequently Asked Questions
The current price of IDLDX is 0.570 SEK — it has decreased by −3.39% in the past 24 hours. Watch IDL DIAGNOSTICS AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange IDL DIAGNOSTICS AB stocks are traded under the ticker IDLDX.
IDLDX stock has risen by 3.64% compared to the previous week, the month change is a 1.79% rise, over the last year IDL DIAGNOSTICS AB has showed a 1.79% increase.
We've gathered analysts' opinions on IDL DIAGNOSTICS AB future price: according to them, IDLDX price has a max estimate of 0.80 SEK and a min estimate of 0.80 SEK. Watch IDLDX chart and read a more detailed IDL DIAGNOSTICS AB stock forecast: see what analysts think of IDL DIAGNOSTICS AB and suggest that you do with its stocks.
IDLDX stock is 7.64% volatile and has beta coefficient of 0.96. Track IDL DIAGNOSTICS AB stock price on the chart and check out the list of the most volatile stocks — is IDL DIAGNOSTICS AB there?
Today IDL DIAGNOSTICS AB has the market capitalization of 131.31 M, it has increased by 4.24% over the last week.
Yes, you can track IDL DIAGNOSTICS AB financials in yearly and quarterly reports right on TradingView.
IDL DIAGNOSTICS AB revenue for the last quarter amounts to 15.30 M SEK, despite the estimated figure of 16.60 M SEK. In the next quarter, revenue is expected to reach 16.20 M SEK.
IDLDX net income for the last quarter is −12.33 M SEK, while the quarter before that showed −9.00 M SEK of net income which accounts for −37.01% change. Track more IDL DIAGNOSTICS AB financial stats to get the full picture.
No, IDLDX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 29, 2025, the company has 20 employees. See our rating of the largest employees — is IDL DIAGNOSTICS AB on this list?
Like other stocks, IDLDX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IDL DIAGNOSTICS AB stock right from TradingView charts — choose your broker and connect to your account.